JP2023545432A5 - - Google Patents
Info
- Publication number
- JP2023545432A5 JP2023545432A5 JP2023521682A JP2023521682A JP2023545432A5 JP 2023545432 A5 JP2023545432 A5 JP 2023545432A5 JP 2023521682 A JP2023521682 A JP 2023521682A JP 2023521682 A JP2023521682 A JP 2023521682A JP 2023545432 A5 JP2023545432 A5 JP 2023545432A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- product according
- pharmaceutical product
- approximately
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063090272P | 2020-10-11 | 2020-10-11 | |
| US63/090,272 | 2020-10-11 | ||
| US202163148038P | 2021-02-10 | 2021-02-10 | |
| US63/148,038 | 2021-02-10 | ||
| US202163193493P | 2021-05-26 | 2021-05-26 | |
| US63/193,493 | 2021-05-26 | ||
| PCT/US2021/054084 WO2022076767A1 (en) | 2020-10-11 | 2021-10-08 | Methods for treating cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545432A JP2023545432A (ja) | 2023-10-30 |
| JP2023545432A5 true JP2023545432A5 (cg-RX-API-DMAC7.html) | 2024-10-11 |
Family
ID=81125466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521682A Pending JP2023545432A (ja) | 2020-10-11 | 2021-10-08 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物コンジュゲート（ａｄｃ）を用いたがんの治療のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230364254A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4225379A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023545432A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230106607A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021356542A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3198359A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302006A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004089A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202228788A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022076767A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019392090A1 (en) | 2018-12-03 | 2021-06-17 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
| WO2024012541A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体药物偶联物及应用 |
| WO2024012536A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体、其抗体药物偶联物及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX347954B (es) * | 2010-09-29 | 2017-05-19 | Agensys Inc | Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12. |
| AU2019342099A1 (en) * | 2018-09-19 | 2021-04-08 | Genentech, Inc. | Therapeutic and diagnostic methods for bladder cancer |
| AU2019392090A1 (en) * | 2018-12-03 | 2021-06-17 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
| AU2020241963A1 (en) * | 2019-03-17 | 2021-11-04 | Vasgene Therapeutics Inc | Treatment of cancers using sEphB4-HSA fusion proteins |
| TW202540197A (zh) * | 2019-08-13 | 2025-10-16 | 美商艾澤西公司 | 以結合191p4d12蛋白質之抗體藥物結合物(adc)治療癌症 |
| KR20230091885A (ko) * | 2020-09-17 | 2023-06-23 | 어젠시스 인코포레이티드 | 191p4d12 단백질에 결합하는 항체 약물 접합체(adc)로 암을 치료하는 방법 |
-
2021
- 2021-10-08 IL IL302006A patent/IL302006A/en unknown
- 2021-10-08 WO PCT/US2021/054084 patent/WO2022076767A1/en not_active Ceased
- 2021-10-08 US US18/030,225 patent/US20230364254A1/en active Pending
- 2021-10-08 CA CA3198359A patent/CA3198359A1/en active Pending
- 2021-10-08 KR KR1020237015737A patent/KR20230106607A/ko active Pending
- 2021-10-08 MX MX2023004089A patent/MX2023004089A/es unknown
- 2021-10-08 TW TW110137596A patent/TW202228788A/zh unknown
- 2021-10-08 JP JP2023521682A patent/JP2023545432A/ja active Pending
- 2021-10-08 EP EP21878582.2A patent/EP4225379A4/en active Pending
- 2021-10-08 AU AU2021356542A patent/AU2021356542A1/en active Pending